Oral antipsychotic prescribing and association with neighbourhood-level socioeconomic status: analysis of time trend of routine primary care data in England, 2011–2016

Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study

(2018) Luke Mordecai et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness

(2017) Thomas RE Barnes et al.   HEALTH TECHNOLOGY ASSESSMENT

Social contacts and loneliness in people with psychotic and mood disorders

(2016) Domenico Giacco et al.   COMPREHENSIVE PSYCHIATRY

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients

(2016) Saínza García et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Schizophrenia and subsequent neighborhood deprivation: revisiting the social drift hypothesis using population, twin and molecular genetic data

(2016) A Sariaslan et al.   Translational Psychiatry

Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study

(2015) Vincent Chin-Hung Chen et al.   SCHIZOPHRENIA RESEARCH

Interventions to Reduce Inappropriate Prescribing of Antipsychotic Medications in People With Dementia Resident in Care Homes: A Systematic Review

(2014) Jo Thompson Coon et al.   Journal of the American Medical Directors Association

Prescribing of antipsychotics in UK primary care: a cohort study

(2014) Louise Marston et al.   BMJ Open

Socioeconomic factors influencing antipsychotic prescription for schizophrenia inpatients in China

(2013) Qiuji Xue et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Changes in Physician Antipsychotic Prescribing Preferences, 2002–2007

(2013) Julie Donohue et al.   PSYCHIATRIC SERVICES

Antipsychotics and mortality in first-onset schizophrenia: Prospective Finnish register study with 5-year follow-up

(2013) Marjo Kiviniemi et al.   SCHIZOPHRENIA RESEARCH

Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010

(2012) Stephen Ilyas et al.   BRITISH JOURNAL OF PSYCHIATRY

Influences on Therapist’s Decisions for Neuroleptic Treatment in Schizophrenia: The Role of Characteristics of the Patient and the Physician

(2012) M. Franz et al.   PHARMACOPSYCHIATRY

Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses

(2012) James B. Kirkbride et al.   PLoS One

National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom

(2011) Philip Prah et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Prescribing Trends in Bipolar Disorder: Cohort Study in the United Kingdom THIN Primary Care Database 1995–2009

(2011) Joseph Hayes et al.   PLoS One

Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies

(2009) H. Verdoux et al.   ACTA PSYCHIATRICA SCANDINAVICA

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Effect of socioeconomic status and parents’ education at birth on risk of schizophrenia in offspring

(2008) Cheryl Corcoran et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY